Malawi has reported significant progress in its campaign against neglected tropical diseases (NTDs), with 1,811,682 school-aged children treated for schistosomiasis in 2025 and 1,457,562 people reached with ivermectin for onchocerciasis.
Malawi is set to save foreign exchange on pharmaceuticals following a $65 million partnership between MUST and Rephaiah, an Icelandic company. The deal will see local manufacturing of drugs at MUST's industrial park.
Year after year, pigs in Malawi come under attack. An attack they rarely survive: African Swine Fever.
Page 1 of 60